Literature DB >> 10560912

Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes.

K Dannaeus1, A Johannisson, K Nilsson, J I Jönsson.   

Abstract

Flt3 ligand (FL) is an important cytokine that affects the proliferation of hematopoietic stem cells and multipotent progenitors. In addition, FL seems to be strongly involved in the differentiation of B cells and macrophages. These two cell types are derived from separate hematopoietic lineages and display distinct surface markers, for instance, the pan-B cell marker B220 (CD45R) and the myelo/monocytic marker Mac-1 (CD11b), respectively. However, reports during several years have shown that some lineage markers can be coexpressed on factor-dependent progenitor cells as well as on some malignant leukemic clones. In the present study, we describe the ability of FL to induce the development and growth of Mac-1+ progenitor cells coexpressing B220 from c-kit+Lin- mouse bone marrow cells. FL was shown to be necessary but not sufficient for the development of Mac-1(-)B220+ cells, because certain other cytokines, in particular IL-6, had to be added to the cultures. An extended characterization of the cells revealed coexpression of other early B-cell markers, i.e., CD24, CD43, and c-kit. They expressed transcripts for c-fms, the receptor for macrophage-colony stimulating factor (M-CSF), and were able to develop into macrophages at high numbers, but not to other myeloid cells. By RT-PCR analysis we could also demonstrate expression of the B-cell associated genes Pax-5, Rag-2, and TdT. In contrast, Mac-1(+)B220- cells from the same cultures did not express any of the B-cell genes, and retained a broader myeloid differentiation capacity. Despite these B-cell associated features, Mac-1(+)B220- cells could not be induced towards B-cell progenitors. Our data suggest that FL triggers the activation of some B-cell associated genes in progenitor cells predestined to macrophage differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560912     DOI: 10.1016/s0301-472x(99)00106-x

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.

Authors:  Stephen M Wiesner; Jennifer L Geurts; Miechaleen D Diers; Rachel J Bergerson; Diane E Hasz; Kelly J Morgan; David A Largaespada
Journal:  Am J Hematol       Date:  2011-07       Impact factor: 10.047

2.  Activated macrophages for treating skin ulceration: gene expression in human monocytes after hypo-osmotic shock.

Authors:  O Frenkel; E Shani; I Ben-Bassat; F Brok-Simoni; G Rozenfeld-Granot; G Kajakaro; G Rechavi; N Amariglio; E Shinar; D Danon
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model.

Authors:  Sarah Greenblatt; Li Li; Christopher Slape; Bao Nguyen; Rachel Novak; Amy Duffield; David Huso; Stephen Desiderio; Michael J Borowitz; Peter Aplan; Donald Small
Journal:  Blood       Date:  2012-02-08       Impact factor: 22.113

4.  A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.

Authors:  Chul Won Choi; Yang Jo Chung; Christopher Slape; Peter D Aplan
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

5.  FLT3 in lineage specification and plasticity.

Authors:  Sarah Greenblatt; Donald Small
Journal:  Oncotarget       Date:  2012-05

6.  Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic State.

Authors:  Matthias Bros; Mahmoud Youns; Verena Kollek; Diana Buchmüller; Franziska Bollmann; Ean-Jeong Seo; Jonathan Schupp; Evelyn Montermann; Svetlana Usanova; Hartmut Kleinert; Thomas Efferth; Angelika B Reske-Kunz
Journal:  Front Pharmacol       Date:  2018-08-17       Impact factor: 5.810

7.  Identification and characterization of B220+/B220- subpopulations in murine Gr1+CD11b+ cells during tumorigenesis.

Authors:  Zhiqian Zhang; Xu Huang; Enlin Wang; Yugang Huang; Rongcun Yang
Journal:  Oncoimmunology       Date:  2021-04-14       Impact factor: 8.110

8.  Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML.

Authors:  Silvia Basilico; Xiaonan Wang; Alison Kennedy; Konstantinos Tzelepis; George Giotopoulos; Sarah J Kinston; Pedro M Quiros; Kim Wong; David J Adams; Larissa S Carnevalli; Brian J P Huntly; George S Vassiliou; Fernando J Calero-Nieto; Berthold Göttgens
Journal:  Nat Commun       Date:  2020-03-16       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.